The Dividend Bro
Contributor since: 2015
Latest Articles
Abbott Laboratories: Great Company, But Is The Price Right?
Time To Board CSX?
The Recent Sell-Off Makes This Industrial Company Much More Attractive
Is United Technologies Attractively Priced?
Canadian Railway's Business And Dividend Track Record Are Impressive
Boeing: Sitting On A Double And We Still Aren't Selling Our Shares
I'm Waiting For A Better Price Before Purchasing Caterpillar
General Dynamics' Recent Acquisition, Dividend History, And Valuation Make The Stock A Compelling Buy
Time To Buy Raytheon?
This Railroad Has Increased Its Dividend By Almost A Third In The Last Year
All Aboard Kansas City Southern?
March To Freedom Fund: Adding Lockheed Martin
McCormick: Great Company, But I'm Waiting For A Pullback
Cummins Is Undervalued
Northrop Grumman Offers Good Value As Currently Priced
Lockheed Martin Is Undervalued
March To Freedom Fund: July Update
Stryker Is One Stock Worth Overpaying For
March To Freedom Fund Mid-Year Review
2 Dividend Champions I Hope To Own In 2018
March To Freedom Fund Update: Income Grew 37% In February
Shareholder Returns Make This Stock A Buy
AbbVie: Time To Trim Our Position?
Portfolio Update: Dividend Income Is Up 35% Year Over Year
United Technologies: Headed Higher
Bullish On McCormick Due To Strong 2018 Guidance
General Dynamics: This Aerospace And Defense Company Has A Long Runway For Growth
Price Decline Makes Johnson & Johnson Even More Attractive
After 2017 Earnings, Is CSX A Buy?
My 2 Favorite High Yielding Stocks Are On Sale Right Now
Dividend Income Was Robust In 2017
March To Freedom Fund Year-End Review